Xylem Inc.
XYL
$108.70
$0.480.44%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.09B | 9.04B | 8.89B | 8.73B | 8.60B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.09B | 9.04B | 8.89B | 8.73B | 8.60B |
| Cost of Revenue | 5.58B | 5.56B | 5.49B | 5.43B | 5.37B |
| Gross Profit | 3.51B | 3.48B | 3.40B | 3.30B | 3.23B |
| SG&A Expenses | 1.94B | 1.93B | 1.95B | 1.92B | 1.90B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.75B | 7.72B | 7.67B | 7.58B | 7.50B |
| Operating Income | 1.34B | 1.32B | 1.23B | 1.16B | 1.10B |
| Income Before Tax | 1.21B | 1.18B | 1.19B | 1.16B | 1.11B |
| Income Tax Expenses | 236.00M | 231.00M | 245.00M | 226.00M | 204.00M |
| Earnings from Continuing Operations | 972.00 | 950.00 | 943.00 | 934.00 | 904.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.00M | 7.00M | 5.00M | 4.00M | 2.00M |
| Net Income | 981.00M | 957.00M | 948.00M | 938.00M | 906.00M |
| EBIT | 1.34B | 1.32B | 1.23B | 1.16B | 1.10B |
| EBITDA | 1.91B | 1.89B | 1.80B | 1.73B | 1.67B |
| EPS Basic | 4.03 | 3.93 | 3.90 | 3.86 | 3.73 |
| Normalized Basic EPS | 3.47 | 3.41 | 3.15 | 2.94 | 2.79 |
| EPS Diluted | 4.02 | 3.92 | 3.88 | 3.84 | 3.71 |
| Normalized Diluted EPS | 3.47 | 3.40 | 3.14 | 2.93 | 2.78 |
| Average Basic Shares Outstanding | 973.13M | 973.47M | 972.93M | 972.41M | 971.61M |
| Average Diluted Shares Outstanding | 975.60M | 976.02M | 975.54M | 975.20M | 974.80M |
| Dividend Per Share | 1.63 | 1.60 | 1.56 | 1.52 | 1.48 |
| Payout Ratio | 40.67% | 40.86% | 40.08% | 39.55% | 39.74% |